News

Filter

Current filters:

USAOphthalmics

201 to 210 of 97524 results

FDA grants Soligenix Fast Track status for SGX301

FDA grants Soligenix Fast Track status for SGX301

07-01-2015

Late-stage biopharma company Soligenix has said that its SGX301 (synthetic hypericin) development program…

OncologyPharmaceuticalRegulationSGX301SoligenixUSA

Aveo Oncology appoints Michael Bailey as president

Aveo Oncology appoints Michael Bailey as president

07-01-2015

Aveo Oncology has appointed Michael Bailey as president, chief executive and director.

AVEO OncologyBoardroomOncologyPharmaceuticalUSA

Shield Therapeutics' MAA for Ferracru accepted for review by EMA

Shield Therapeutics' MAA for Ferracru accepted for review by EMA

07-01-2015

Independent UK pharma company Shield Therapeutics has received acceptance for review of the Marketing…

FerracruHematologyPharmaceuticalRegulationShield TherapeuticsUK

Pfizer enters race to develop Duchenne muscular dystrophy therapy

Pfizer enters race to develop Duchenne muscular dystrophy therapy

07-01-2015

US pharma giant Pfizer is the latest company to enter the race to develop a therapy for Duchenne muscular…

GeneticsPF-06252616PfizerPharmaceuticalResearchUSA

Sobi extends distribution agreement with Exelixis for Cometriq

Sobi extends distribution agreement with Exelixis for Cometriq

07-01-2015

Swedish Orphan Biovitrum today announced that its agreement with Exelixis has been restructured and extended…

BiotechnologyCometriqEuropeExelixisMarkets & MarketingOncologySobi

CHMP recommends approval of Newron/Zambon's Xadago for Parkinson's disease

CHMP recommends approval of Newron/Zambon's Xadago for Parkinson's disease

07-01-2015

Italy-based Newron Pharmaceuticals and its partner Zambon have received a recommendation from the Euroean…

ItalyNeurologicalNewron PharmaceuticalsPharmaceuticalRegulationXadagoZambon

ThromboGenics NV appoints Dominique Vanfleteren as chief financial officer

ThromboGenics NV appoints Dominique Vanfleteren as chief financial officer

07-01-2015

Ophthalmic specialist ThromboGenics NV has appointed Dominique Vanfleteren as chief financial officer.

BelgiumBoardroomOphthalmicsPharmaceuticalThromboGenics

Isis Pharmaceuticals appoints Sarah Boye as chief business officer

Isis Pharmaceuticals appoints Sarah Boye as chief business officer

07-01-2015

Isis Pharma, the biopharma Crohn’s disease specialist, has appointed Sarah Boyce to the newly-created…

BiotechnologyBoardroomIsis PharmaIsis PharmaceuticalsUSA

Alkermes rises on positive ALKS 5461 results

07-01-2015

Shares of Ireland-headquartered biotech firm Alkermes closed up 2.6% to $60.93, having risen as much…

AlkermesALKS 5461BiotechnologyNeurologicalResearch

201 to 210 of 97524 results

Back to top